AOLS Stock - Aeolus Pharmaceuticals, Inc.
Unlock GoAI Insights for AOLS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $2.08M | $3.11M | $9.63M | $3.93M | $7.29M |
| Gross Profit | $-805,000 | $-398,000 | $2.67M | $568,000 | $7.29M |
| Gross Margin | -38.8% | -12.8% | 27.7% | 14.5% | 100.0% |
| Operating Income | $-3,273,000 | $-2,626,000 | $-80,000 | $-2,698,000 | $-2,371,000 |
| Net Income | $-3,558,000 | $-2,628,000 | $-80,000 | $-3,208,000 | $1.70M |
| Net Margin | -171.4% | -84.5% | -0.8% | -81.7% | 23.3% |
| EPS | $-0.04 | $-0.02 | $-0.00 | $-0.03 | $0.01 |
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.
Visit WebsiteEarnings History & Surprises
AOLSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2017 | Aug 14, 2017 | — | $-0.01 | — | — |
Q2 2017 | May 15, 2017 | — | $-0.01 | — | — |
Q1 2017 | Feb 17, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 21, 2016 | — | $-0.01 | — | — |
Q3 2016 | Aug 15, 2016 | — | $-0.01 | — | — |
Q2 2016 | May 16, 2016 | — | $-0.02 | — | — |
Q1 2016 | Feb 16, 2016 | — | $-0.01 | — | — |
Q4 2015 | Dec 18, 2015 | — | $-0.00 | — | — |
Q3 2015 | Aug 17, 2015 | — | $-0.01 | — | — |
Q2 2015 | May 15, 2015 | — | $-0.01 | — | — |
Q1 2015 | Feb 13, 2015 | — | $-0.01 | — | — |
Q4 2014 | Dec 22, 2014 | — | $-0.00 | — | — |
Q3 2014 | Aug 15, 2014 | — | $0.01 | — | — |
Q2 2014 | May 15, 2014 | — | $-0.00 | — | — |
Q1 2014 | Feb 14, 2014 | — | $-0.01 | — | — |
Q4 2013 | Dec 23, 2013 | — | $-0.00 | — | — |
Q3 2013 | Aug 14, 2013 | — | $-0.01 | — | — |
Q2 2013 | May 15, 2013 | — | $-0.01 | — | — |
Q1 2013 | Feb 19, 2013 | — | $-0.07 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-0.11 | — | — |
Latest News
Frequently Asked Questions about AOLS
What is AOLS's current stock price?
What is the analyst price target for AOLS?
What sector is Aeolus Pharmaceuticals, Inc. in?
What is AOLS's market cap?
Does AOLS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AOLS for comparison